Therapeutic Potential of “Exosomes Derived Multiple Allogeneic Proteins Paracrine Signaling: Exosomes d-MAPPS” is Based on the Effects of Exosomes, Immunosuppressive and Trophic Factors Cover

.blurhash-client-img { display: none !important; }

Therapeutic Potential of “Exosomes Derived Multiple Allogeneic Proteins Paracrine Signaling: Exosomes d-MAPPS” is Based on the Effects of Exosomes, Immunosuppressive and Trophic Factors

EABR. Experimental and Applied Biomedical Research

Volume 20 (2019): Issue 3 (September 2019)

By: Carl Randall Harrell, Crissy Fellabaum, Bojana Simovic Markovic, Aleksandar Arsenijevic and Vladislav Volarevic

Open Access

|Nov 2019

Authors

Carl Randall Harrell

United States of America

Crissy Fellabaum

United States of America

Bojana Simovic Markovic

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia

Aleksandar Arsenijevic

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia

Vladislav Volarevic

drvolarevic@yahoo.com

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia

DOI: https://doi.org/10.2478/sjecr-2018-0032 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454

Journal RSS Feed

Language: English

Page range: 189 - 197

Submitted on: Sep 3, 2018

|

Accepted on: Sep 4, 2018

|

Published on: Nov 7, 2019

Published by: University of Kragujevac, Faculty of Medical Sciences

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

mesenchymal stem cells,

immunosuppression,

differentiation

Related subjects:

Clinical medicine,

Clinical medicine, other

© 2019 Carl Randall Harrell, Crissy Fellabaum, Bojana Simovic Markovic, Aleksandar Arsenijevic, Vladislav Volarevic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 20 (2019): Issue 3 (September 2019)Next article